
Evotec
Evotec are a R&D biotech that offers accelerating, high value pipeline co-creation partnerships and comprehensive CRO/CDMO services – always striving for highest quality, capital efficient execution of R&D programs from disease understanding towards IND, Phase 1, and beyond. Our expertise spans across therapeutic/disease areas and most modalities, especially small molecules and biotherapeutics. We take pride in acting as "drug hunters" in deep collaboration with our partners to advance science. At the core of our operations are our industrialized, AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies. These platforms are instrumental in enhancing disease understanding and ensuring human relevance in our research. By integrating AI and continuous manufacturing technology, we facilitate better access to high-quality biotherapeutics, revolutionizing the way treatments are developed and produced.
Latest Content

High-Sensitivity Proteomics: The Next Frontier for Spatial and Single-Cell Biology

Evotec and Novo Nordisk Enter Into Technology Development Partnership To Support Next-Generation Cell Therapies

Harnessing microRNAs To Direct Bone and Cartilage Repair

Unlocking the Potential of miRNA-Targeted Therapies

How AI and Machine Learning Can Improve Scientific Data Handling

Evotec Announces Progress in Strategic Neuroscience Partnership With Bristol Myers Squibb

The Omics Revolution: Multiomics and the Future of Biomedical Research

Evotec’s ScreenPep™ : the new benchmark in high-throughput proteomics

Mass Spectrometry-Based Solutions for Drugging the Undruggable
